blog

The best resident study stack in 2026 is not one magical AI tool. It is a three-layer system: a reference and explanation layer, a memory layer, and a calibration layer. AMBOSS, An...

Pathway is no longer a separate story. After Doximity acquired Pathway in August 2025, it announced in September 2025 that Pathway’s corpus and AI model were fully integrated into ...

AMBOSS AI Mode and OpenEvidence are both trying to become physicians’ first stop for clinical questions in 2026, but they begin from very different assumptions. AMBOSS AI Mode is b...

DoxGPT and OpenEvidence are both free for verified U.S. clinicians, but they begin from different workflow assumptions. DoxGPT is strongest when the task starts with documentation,...

The next frontier in clinician AI is no longer just note-taking — it is what happens after the consultation. As AI scribes expand into coding, referral drafting, Advice & Guidance ...

Tandem Health is no longer just an AI scribe story. Its public product and funding announcements now point toward a broader ambition: an AI-native operating system for clinical wo...

Clinicians are already using AI in meaningful numbers, but uncertainty about safety, privacy, liability, and governance remains high. This article sets out a practical green / ambe...

Advice & Guidance and formal referral are both core NHS e-RS workflows, but they solve different problems. Advice & Guidance is clinician-to-clinician communication for patient-spe...

HealthPathways and NICE CKS are both valuable primary care resources, but they solve different problems. NICE CKS gives GPs a concise, evidence-based national baseline for common a...

UK clinicians increasingly use general chatbots like ChatGPT, but the NHS is now shifting toward governed point-of-care AI stacks: tools that are procured, assured, integrated, and...

ChatGPT is already being used by UK doctors—often for admin, letters, education and clinical thinking support—but many GPs describe a “wild west” of inconsistent guidance and uncle...

Heidi Evidence is increasingly relevant for UK GPs, with citation-backed answers, regional source positioning, and named partners such as NICE, BMJ Group and MIMS. But can an evide...